Soluble B7-H6 has been shown to contribute to defective expression of NKp30 on circulating NK cells from hepatocellular carcinoma, ovarian carcinoma and neuroblastoma patients, further linking elevated B7-H6 with NK cell dysfunction [24–26]. Here, NCR3 is linked to ovarian carcinoma.